Strontium compound for treatment of sub-dermal soft tissue pain

Details Strontium compound for treatment of sub-dermal soft tissue pain Strontium compound for treatment of sub-dermal soft tissue pain

2007-07-10

2007-07-10

Pak, John (Department: 1616)

Drug, bio-affecting and body treating compositions

Inorganic active ingredient containing

Phosphorus or phosphorus compound

C424S677000, C424S715000, C424S718000, C424S722000, C514S557000, C514S574000, C514S936000, C514S946000, C514S947000

Reexamination Certificate

active

10488162

ABSTRACT:
The invention provides a method of treatment of a human or non-human subject to combat sub-dermal soft tissue pain therein, said method comprising administering to a subject in need thereof an effective amount of a physiologically tolerable strontium compound.

REFERENCES:
patent: 3865933 (1975-02-01), Mudge
patent: 3988434 (1976-10-01), Schole et al.
patent: 4083965 (1978-04-01), Bluhm
patent: 4141359 (1979-02-01), Jacobsen et al.
patent: 4146606 (1979-03-01), Yamaga et al.
patent: 4363818 (1982-12-01), Gottlieb
patent: 4634589 (1987-01-01), Scheller
patent: 4645662 (1987-02-01), Nakashima et al.
patent: 4650668 (1987-03-01), Barron et al.
patent: 4756909 (1988-07-01), Revici
patent: 4866046 (1989-09-01), Amer
patent: 5188818 (1993-02-01), Merianos et al.
patent: 5234971 (1993-08-01), Imai et al.
patent: 5260289 (1993-11-01), Hyodo et al.
patent: 5330746 (1994-07-01), Friedman et al.
patent: 5380530 (1995-01-01), Hill
patent: 5716625 (1998-02-01), Hahn et al.
patent: 5804203 (1998-09-01), Hahn et al.
patent: 5851512 (1998-12-01), Fischer
patent: 5851556 (1998-12-01), Breton et al.
patent: 5855870 (1999-01-01), Fischer
patent: 5856356 (1999-01-01), Tsouderos et al.
patent: 5866168 (1999-02-01), De Lacharriere et al.
patent: 5958436 (1999-09-01), Hahn et al.
patent: 5958462 (1999-09-01), McLean
patent: 6139850 (2000-10-01), Hahn et al.
patent: 6168809 (2001-01-01), De Lacharriere et al.
patent: 1 179 267 (1984-12-01), None
patent: 1179944 (1998-04-01), None
patent: 0 575 841 (1993-06-01), None
patent: 0 834 319 (1998-04-01), None
patent: WO 86/03413 (1986-06-01), None
patent: WO 94/09798 (1994-05-01), None
patent: WO 96/01634 (1996-01-01), None
patent: WO 96/19184 (1996-06-01), None
patent: WO 97/48371 (1997-12-01), None
patent: WO 98/03179 (1998-01-01), None
patent: WO 98/47519 (1998-10-01), None
The Merck Index, 12thed., Merck & Co., Inc., Whitehouse Station, NJ, 1996, p. 551.
Martindale The Extra Pharmacopoeia, 30thed., The Pharmaceutical Press, London, 1993, pp. 1101-1102.
Chemical Abstracts 110:218973 (1989).
Chemical Abstracts 99:182515 (1983).
Hahn et al,American Society for Dermatologic Surgery Inc., 25(9):689-694 (1999).
Early et al,Health Physics, 69(5):677-693 (1995).
Jill Stein, “DG Dispatch—ACAAI: Strontium Supresses Itching In Allergy Skin Reactions”,Doctor's Guide(Nov. 5, 2000).
“Cosmederm—7™”, Product Information (May 25, 2002).
“Cosmederm—7™”, Cosmederm Technology (May 25, 2002).
Meunier et al, “Endocrine Care”,J. of Clonical Endocrinology&Metabolism, 87(2):2060-2066.
Zaichik et al, No. 34810z,Chem. Abstracts, 70:62 (1969).
Moya-Hernandez et al, No. 131:266581g,Chem. Abstracts, I-Pharmacology, 131(20):26 (1999).
Ghandour et al, No. 110:142402w,Chem. Abstracts, 68-Equilibriums, Solutions, 110:479 (1989).
Krishnan et al, No. 90:66866b,Chem. Abstracts, 90:56 (1979).
Kaufmann et al,Arch. Pharm., 278:443-448 (1941).
Kaufmann et al, “Complex Barbituric Acid Compounds”, Column 1407,Chem. Abstracts, vol. 32 (1937).
Perrier, “Strontium Tricitrate”, Column 11860,Chem.,Abstracts, vol. 61 (May 1964).
Simon,Boll. Soc. Ital. Biol. Sper., 4:1197-1199 (1929).
Simon,Arch. Farmacol. Sper., Chem. Abstracts, Column 4472, vol. 28 (1934).
Yannis, No. 128:97710d,Chem. Abstracts, 1-Pharmacology, 128(9):68 (1998).
Neirinckx, No. 116:241750p,Chem. Abstracts, 116:408 (1992).
Friedman, No. 114:88683f,Chem. Abstracts, 63-Pharmacology, 114:445 (1991).
Surovezhin, No. 741z,Chem. Abstracts, 5-Radiation Biochem.., 73:63 (1970).
Gassmann,Schweiz Med. Wochschr., 68:291-292 (1938).
Sankaram, No. 103:105312b,Chem. Abstracts, 34-Amino Acids, Peptides, Proteins, 103:659 (1985).
Peppas et al,Biomaterials, 17(16):1553-1561 (1996).
Lehr,Eur. J. Drug Metab. Pharmacokinet., 21(2):139-148 (1996).
Joshi,Ocul. Pharmacol., 10(1):29-45 (1994).
Lehr,Crit. Rev. Ther. Drug Carrier Syst., 11(2-3):119-160 (1994).
Bernkop-Schnurch et al,Adv. Drug Deliv. Rev., 52(2):127-137 (2001).
Morishita et al,Nippon Rinsho, 59(11):2255-2260 (2001).
Singla et al,J. Pharm. Pharmacol., 53(8):1047-1067 (2001).
Bures et al,J. Control Release, 72(1-3):25-33 (2001).
Woodley,Clin. Pharmacokinet, 40(2):77-84 (2001).
Takeuchi et al,Adv. Drug Deliv. Rev., 47(1):39-54 (2001).
Sakuma et al,Adv. Drug Deliv. Rev., 47(1):21-37 (2001).
Muller et al,Adv. Drug Deliv. Rev., 47(1):3-19 (2001).
Ugwoke et al,J. Pharm. Pharmacol., 53(1):3-21 (2001).
Dostalova et al,Ceska Slov. Farm., 49(2):55-61 (2000).
Singla et al,Drug Deliv. Ind. Pharm., 26(9):913-924 (2000).
Aungst,J. Pharma Sci., 89(4):429-442 (2000).
Huang et al,J. Control. Rel., 65(1-2):63-71 (2000).
Bernkop-Schnurch,Int. J. Pharm., 194(1):1-13 (2000).
Hwang et al,Crit. Rev. Ther. Drug Carrier Syst., 15(3):243-284 (1998).
Bernkop-Schnurch,J. Control. Rel., 52(1-2):1-16 (1998).
Vyas et al,Pharmazie, 52(5):339-345 (1997).
Gwak et al,Arch Pharm. Res., 25(3):392-396 (2002).
Karande et al,Pharm. Res., 19(5):655-660 (2002).
Aguilar et al,BMC Infect. Dis., 2(1):9 (2002).
Touitou et al,J. Control. Rel., 80(1-3):1-7 (2002).
Wiechers et al,Drug. Des. Deliv., 6(2):87-100 (1990).
Williams et al,Crit. Rev. Ther. Drug Carrier Syst., 9(3-4):305-353 (1992).
Hermens,Pharm. Weekbl. Sci., 14(14A):253-257 (1992).
Berti et al,Mayo Clin. Proc., 70(6):581-586 (1995).
Bach et al,Eur. J. Pharm. Biopharm., 46(1):1-13 (1998).
Marjukka Suhonen et al,J. Control Rel., 59(2):149-161 (1999).
Kanikkannan et al,Curr. Med. Chem., 7(6):593-608 (2000).
Mastropaolo et al,J. Med. Chem., 44(2):269-273 (2001).
Moraes et al,Br. J. Clin. Pharmacol., 32(4):441-445 (1991).
Moraes et al,Br. J. Clin. Pharmacol., 31(4):423-427 (1991).
Llobet et al,Res. Commun Chem. Pathol. Pharmacol., 72(2):243-246 (1991).
Colomina et al,Vet. Hum. Toxicol., 33(2):121-124 (1991).
Llobet et al,Arch Environ Contam. Toxicol., 21(4):612-620 (1991).
Llobet et al,Vet. Hum. Toxicol., 34(1):7-9 (1992).
Delannoy et al,Metabolism, 51(7):906-911 (2002).
Llobet et al,Health Phys., 65(5):541-544 (1993).
Meunier,Joint Bone Spine, 68(6):576-581 (2001).
Beuhler et al,Bone, 29(2):176-179 (2001).
Dahl et al,Bone, 28(4):446-453 (2001).
Henrotin et al,J. Bone Miner Res., 16(2):299-308 (2001).
Canalis et al,Bone, 18(6):517-523 (1996).
Boivin et al,J. Bone Miner Res., 11(9):1302-1311 (1996).
Reinster et al,Drugs R D, 1(3):195-201 (1999).
Zhai et al,Contact Dermatitis, 42(2):98-100 (2000).
Hahn et al,Dermatol. Surg., 25(9):689-694 (1999).
Powis et al,Br. Med. J., 2(6045):1166-1168 (1976).
Kishore et al,J. Endod., 28(1):34-35 (2002).
Guay et al,Pharmacotherapy, 21(9):1070-1078 (2001).
Markowitz,Compendium, 14(8):1032, 1034 passim, quiz 1046 (1993).
Collaert et al,Endod, Dent. Traumatol., 7(4):145-152 (1991).
Mazor et al,Clin. Prev. Dent., 13(3):21-25 (1991).
Andronikaki-Feldani et al,Hell Stomatol Chron., 32(2):139-147 (1988).
Minkoff et al,J. Periodontol, 58(7):470-474 (1987).
Krauser,J. Prosthet. Dent., 56(3):307-311 (1986).
Krauser,J. Prosthet Dent., 56(2):153-156 (1986).
Clark et al,J. Periodontal Res., 20(2):212-219 (1985).
Uchida et al,J.Peridontol, 51(10):578-581 (1980).
Gedalia et al,J. Peridontol, 49(5):269-272 (1978).
Uchida et al,Nippon Shishubyo Gakkai Kaishi, 22(3):486-191 (1980).
Marie et al,Calcif. Tissue Int., 69(3):121-129 (2001).
“Facts About Sensitive Teeth”,CDS Rev., 94(1):34 (2001).
Monaenkova et al,Zhurnal fizicheskoy khimii, 9(LVII):2173-2176 (1983).
Lashmar et al,J. Pharm. Pharmacol., 41:118-121 (1989).
Hahn, “Modulation of Neurogenic Inflammation by Strontium”,CRC Press, pp. 261-272 (2000).
Hahn, “Anti-Irritants for Sensory Irritation”,Handbook of Cosmetic Science and Technology, pp. 285-298 (2001).

Affiliated with

Also associated with

Rating

Strontium compound for treatment of sub-dermal soft tissue pain does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Strontium compound for treatment of sub-dermal soft tissue pain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Strontium compound for treatment of sub-dermal soft tissue pain will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3742956